Lilly Hits Record High After Mounjaro Fuels Forecast Raise :

Eli Lilly on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment.

Related Keywords

New York , United States , Bengaluru , Karnataka , India , Mohit Bansal , Bhanvi Satija , Sriraj Kalluvila , Patrick Wingrove , Evan Seigerman , Wells Fargo , Reuters , Novo Nordisk , Mariam Sunny , Obesity , Bese , Weight Loss , Practice Management , Weight Management , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Incretin Hormones , Incretins , Health Insurance , Health Insurance Reimbursement , Insurance ,